{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:44:16Z","timestamp":1746816256568,"version":"3.37.3"},"reference-count":33,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1095024"],"award-info":[{"award-number":["OPP1095024"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>The decades long effort to eradicate polio is nearing the final stages and oral polio vaccine (OPV) is much to thank for this success. As cases of wild poliovirus continue to dwindle, cases of paralysis associated with OPV itself have become a concern. As type-2 poliovirus (one of three) has been certified eradicated and a large proportion of OPV-related paralysis is caused by the type-2 component of OPV, the World Health Assembly endorsed the phased withdrawal of OPV and the introduction of inactivated polio vaccine (IPV) into routine immunisation schedules as a crucial step in the polio endgame plan. The rapid pace of IPV scale-up and uptake required adequate supply, planning, advocacy, training and operational readiness. Similarly, the synchronised switch from trivalent OPV (all three types) to bivalent OPV (types 1 and 3) involved an unprecedented level of global coordination and country commitment. The important shift in vaccination policy seen through global IPV introduction and OPV withdrawal represents an historical milestone reached in the polio eradication effort.<\/jats:p>","DOI":"10.1136\/archdischild-2016-311171","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T02:42:25Z","timestamp":1484707345000},"page":"362-365","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["The polio endgame: rationale behind the change in immunisation"],"prefix":"10.1136","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-9645","authenticated-orcid":false,"given":"Julie","family":"Garon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"key-10.1136\/archdischild-2016-311171-1","unstructured":"Global Polio Eradication Initiative > Data and monitoring > Polio this week > Wild poliovirus list [Internet]. [cited 2015 Apr 22]. http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx"},{"key":"key-10.1136\/archdischild-2016-311171-2","first-page":"598","article-title":"28\u2014Poliovirus vaccine\u2014live","volume-title":"Vaccines (Sixth Edition) [Internet]","author":"Sutter","year":"2013"},{"key":"key-10.1136\/archdischild-2016-311171-3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S1473-3099(15)00059-6","article-title":"Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000\u201312","volume":"15","author":"Iqbal","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.1136\/archdischild-2016-311171-4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMp1406250","article-title":"Lessons from a public health emergency\u2014importation of wild poliovirus to Israel","volume":"371","author":"Kopel","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2016-311171-5","unstructured":"Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013\u20132018 [Internet]. 2013. http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/StrategyWork\/PEESP_EN_US.pdf"},{"key":"key-10.1136\/archdischild-2016-311171-6","unstructured":"Global eradication of wild poliovirus type 2 declared [Internet]. Global Polio Eradication Initiative > News stories. 2015 (cited 6 October 2015). http:\/\/www.polioeradication.org\/mediaroom\/newsstories\/Global-eradication-of-wild-poliovirus-type-2-declared\/tabid\/526\/news\/1289\/Default.aspx"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2016-311171-7","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.1136\/archdischild-2016-311171-8","unstructured":"Report of the SAGE Polio Working Group Meeting 7\u20138 September 2015 [Internet] (cited 26 October 2015). http:\/\/www.who.int\/immunization\/sage\/meetings\/2015\/october\/2_SAGE_WG_report_draft_Final_clean.pdf?ua=1"},{"key":"key-10.1136\/archdischild-2016-311171-9","unstructured":"Global Polio Eradication Initiative > Data and monitoring > Polio this week > Circulating vaccine-derived poliovirus [Internet] (cited 6 April 2015). http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Circulatingvaccinederivedpoliovirus.aspx"},{"key":"key-10.1136\/archdischild-2016-311171-10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"key-10.1136\/archdischild-2016-311171-11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14760584.2016.1140041","article-title":"Polio endgame: the global switch from tOPV to bOPV","volume":"15","author":"Garon","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"key-10.1136\/archdischild-2016-311171-12","unstructured":"Agenda Item 15.2 Poliomyelitis. In Geneva, Switzerland: World Health Organization; 2015 (cited 18 June 2015). http:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA68\/A68_R3-en.pdf"},{"key":"key-10.1136\/archdischild-2016-311171-13","unstructured":"WER. Polio Vaccines: WHO position paper, January 2014 [Internet]. World Health Organization; 2014 Feb p. 73\u201392. Report No.: 9. http:\/\/www.who.int\/wer\/2014\/wer8909.pdf?ua=1"},{"volume-title":"WHO|IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening [Internet]","key":"key-10.1136\/archdischild-2016-311171-14"},{"key":"key-10.1136\/archdischild-2016-311171-15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Estivariz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"key-10.1136\/archdischild-2016-311171-16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.1136\/archdischild-2016-311171-17","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"key":"key-10.1136\/archdischild-2016-311171-18","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2016-311171-19","unstructured":"Polio vaccines: WHO position paper\u2014March, 2016 [Internet]. World Health Organization; 2016 Mar (cited 2016 Mar 30), p. 145\u201368 (Weekly Epidemiologic Record). Report No.: 91. http:\/\/www.who.int\/wer\/2016\/wer9112.pdf?ua=1"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2016-311171-20","first-page":"S2","article-title":"The need and potential of inactivated poliovirus vaccine","volume":"53","author":"Garon","year":"2016","journal-title":"Indian Pediatr"},{"key":"key-10.1136\/archdischild-2016-311171-21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.78.3.291","article-title":"Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks","volume":"78","author":"Hinman","year":"1988","journal-title":"Am J Public Health"},{"issue":"(RR-3)","key":"key-10.1136\/archdischild-2016-311171-22","first-page":"1","article-title":"Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"key-10.1136\/archdischild-2016-311171-23","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.292.14.1696","article-title":"Vaccine policy changes and epidemiology of poliomyelitis in the United States","volume":"292","author":"Alexander","year":"2004","journal-title":"JAMA"},{"key":"key-10.1136\/archdischild-2016-311171-24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"issue":"(Suppl 4)","key":"key-10.1136\/archdischild-2016-311171-25","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2011.10.005","article-title":"The global polio eradication initiative: lessons learned and prospects for success","volume":"29","author":"Aylward","year":"2011","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2016-311171-26","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2015\u2014conclusions and recommendations [Internet]"},{"key":"key-10.1136\/archdischild-2016-311171-27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"key-10.1136\/archdischild-2016-311171-28","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande","year":"2003","journal-title":"Indian J Med Res"},{"key":"key-10.1136\/archdischild-2016-311171-29","first-page":"347","article-title":"Stopping poliovirus vaccination after eradication: issues and challenges","volume":"78","author":"Wood","year":"2000","journal-title":"Bull World Health Organ"},{"key":"key-10.1136\/archdischild-2016-311171-30","unstructured":"World Health Organization. Guidelines for Containment of Poliovirus Following Type-Specific Polio Eradication\u2014Worldwide, 2015 [Internet] (cited 20 October 2015). http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6433a5.htm?s_cid=mm6433a5_w"},{"issue":"1","key":"key-10.1136\/archdischild-2016-311171-31","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1093\/infdis\/jiu043","article-title":"Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication","volume":"210","author":"McKinlay","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.1136\/archdischild-2016-311171-32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"issue":"(Suppl 1)","key":"key-10.1136\/archdischild-2016-311171-33","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","article-title":"Global polio eradication initiative: lessons learned and legacy","volume":"210","author":"Cochi","year":"2014","journal-title":"J Infect Dis"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2016-311171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T11:04:28Z","timestamp":1601118268000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2016-311171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,3,20]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/archdischild-2016-311171"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2016-311171","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"type":"print","value":"0003-9888"},{"type":"electronic","value":"1468-2044"}],"subject":[],"published":{"date-parts":[[2017,1,17]]}}}